Skip to content

J-147

Also called curcumin-derived neuroprotective

Derived from curcumin but a distinct molecule with far better brain penetration.

  • TypeSmall molecule
  • FormOral
  • Researched forCognitive & Mood

Where to get J-147

Disguised Alpha
Oral
Code CAMERON

21+ to enter. The only form sold. Research compound, not approved for human use.

Shop oral at Disguised Alpha

The short version

  • Why people research itFocus, memory, neuroprotection, mood and stress resilience.
  • What the evidence isThere is nothing to cite.
  • What to watchUnusual fatigue or exercise intolerance.

How J-147 works

J-147 is interesting for a reason that has nothing to do with its structure: it was not designed against amyloid. Twenty years of Alzheimer's drug development aimed at a single protein and mostly failed.

The chemistry. J-147 is a synthetic derivative of curcumin, retaining the pharmacophore that gave curcumin its activity in neuroprotection assays while removing the properties that made curcumin useless as a drug: negligible oral bioavailability, rapid conjugation and poor brain penetration. The compound is curcumin's activity without curcumin's pharmacokinetics, which is a much more useful description than calling it a curcumin analog Qiu 2023.

Its target was identified as mitochondrial ATP synthase — modestly inhibiting it triggers an adaptive stress response that raises mitochondrial calcium buffering and downstream NGF and BDNF. It was selected in ageing-brain models rather than amyloid models, which is why its profile reads differently from the Alzheimer's drugs it sits beside.

  • Oral

On the goal map: Cerebral metabolism & blood flow (Focus, memory & cognition)

Research on J-1474 evidence notes: clinical, correlative, mechanism

Each note is labeled by the kind of evidence it stands on. Unproven is not ineffective: a missing trial means nobody has run it yet. How the evidence tiers work

Evidence on file: Preclinical (extensive rodent, Salk Institute); early human safety work.

Human clinical evidence

  • There is nothing to cite. Which is the conservative direction, but neither figure was established in a person.

Correlative data

  • Curcumin itself has a long record of poor oral bioavailability and poor brain penetration — the problem J-147 was built to solve. Read the parent compound's disappointing trial history as context for why a derivative was needed, not as evidence the derivative works.

How the mechanism reads

  • Its molecular target was identified as mitochondrial ATP synthase. Modestly inhibiting it triggers an adaptive stress response that raises mitochondrial calcium buffering and downstream NGF and BDNF — a hormetic mechanism rather than a blocking one.

    Mechanistic
  • It was selected in ageing-brain models rather than amyloid models, which is why its preclinical profile reads differently from the Alzheimer's drugs it sits beside. Extensive rodent data; almost no human data.

    Experimental, animal or cell

Sources

  • Qiu F, et al. Current evidence for J147 as a potential therapeutic agent in nervous system disease: a narrative review. BMC Neurology 2023 · PMID 37674139
  • Qiu F, et al. J147 ameliorates sepsis-induced depressive-like behaviors in mice by attenuating neuroinflammation through regulating the TLR4/NF-kappaB signaling pathway. Journal of Molecular Histology 2023 · PMID 37676534
  • Austad SN, et al. Targeting whole body metabolism and mitochondrial bioenergetics in the drug development for Alzheimer's disease. Acta Pharmaceutica Sinica B 2022 · PMID 35256932
  • Patro S, et al. ATP Synthase and Mitochondrial Bioenergetics Dysfunction in Alzheimer's Disease. International Journal of Molecular Sciences 2021 · PMID 34681851
  • Rahman MA, et al. Drug Target to Alleviate Mitochondrial Dysfunctions in Alzheimer's Disease: Recent Advances and Therapeutic Implications. Current Neuropharmacology 2024 · PMID 39234772

J-147 safety basicsWho should avoid it, what to expect, what to watch

Avoid if

  • Mitochondrial disease, since it partly inhibits ATP synthase.
  • Liver disease, as the curcumin-derived molecule is processed hepatically with no human data.
  • Active cancer, as altering energy handling can matter both ways.
  • Pregnancy or under 18, with no human safety data at all.

What’s expected

  • An adaptive stress response from mild ATP synthase inhibition, raising mitochondrial calcium buffering.
  • Brain neurotrophic signaling in mouse studies.
  • No human effect has been measured.

Watch for

  • Unusual fatigue or exercise intolerance.
  • Muscle weakness or cramps.
  • Persistent headaches.

Labs that tell you it’s working

  • Comprehensive Metabolic Panel: bicarbonate and liver enzymes capture energy-metabolism stress.
  • HbA1c: mouse studies reported whole-body metabolic shifts.
  • hs-CRP: inflammation read for an unstudied molecule.

Curcumin-derived molecule targeting mitochondrial ATP synthase; modest inhibition triggers an adaptive stress response, with no published human safety data. PMID 35256932 PMID 37674139

Bloodwork to runHow you would know it is working: 9 tests in one order, code CAMERON

J-147 FAQ4 common questions

Is J-147 approved for human use?
No. J-147 is a research compound.
What is J-147 researched for?
Focus, memory, neuroprotection, mood and stress resilience.
Which labs show whether it's doing anything?
Comprehensive Metabolic Panel; HbA1c; hs-CRP: a baseline before you start and a recheck after. The panel on this page orders them in one cart.
Where's the full protocol?
In the Skool lesson for J-147: the protocol, dose and schedule, timing, what to stack, the cycle answer, the bloodwork plan and the cheat sheet. Protocol & dosing live there, not on the public site.
The Before-You-Stack Lab Kit cover

The free Before‑You‑Stack Lab Kit

The 12 labs I’d run before any protocol, what each one tells you, add-ons by goal and how to order them yourself. The PDF is yours straight away.

After that it is about two emails a week: a marker, a compound or a protocol. Unsubscribe in one click.

Protocol & dosing: inside Skool

This page covers what J-147 is. Skool covers how it is run.

Free on this page

What J-147 is and how it works · The research, labeled by the kind of evidence · Its own safety lines and the bloodwork panel

  • What J-147 is and how it works
  • The research, labeled by the kind of evidence
  • Its own safety lines and the bloodwork panel

Members get

  • The reported research range, and how each number was reached
  • The protocols: what to run together, in what order, for how long and when to stop
  • The members' prep tool, and live Q&A with Cam every Tuesday
Join Skool $10/mo1,500+ members, 5.0 rating from 15 reviews. Cancel anytime.
The members' Prep Bench in Skool: the compound finder (no dose shown)
The members’ Prep Bench

Want it built around you?

The coaching app, with sample data

1-on-1 coaching with Cam

Your plan, your bloodwork and your check-ins, built around you.

Research Protocol $150/mo · Full Coaching $250/mo

See coaching

One question? Book a 15-minute consult

A call with Cam on the one thing you are stuck on.

$75 per call

Book a consult

Educational and research purposes only. Not medical advice. Research compounds are discussed for research use only, not human use. Some links are affiliate links; Cam may earn a commission at no extra cost to you. Medical disclaimer & affiliate disclosure

Buy with codeJoin Skool